Ipca Laboratories rose 1% to Rs 386.35 at 13:48 IST on BSE as the company mulls share buyback.
The board of Ipca Laboratories will meet on 11 November 2008 to consider a share buyback. The company made the announcement on 1 November 2008.
The stock hit a high of Rs 459.85 and a low of Rs 386.35 so far during the day. The stock had a 52-week high of Rs 760 on 10 January 2008 and a 52-week low of Rs 331 on 29 October 2008.
The small-cap pharmaceuticals company has an equity capital of Rs 25.09 crore. Face value per share is Rs 10.
The current price of Rs 386.35 discounts its Q2 September 2008 annualised EPS of Rs 58.21, by a PE multiple of 6.63.
Ipca Laboratories’ net profit rose 19.6% to Rs 36.51 crore on a 21.4% rise in sales to Rs 347.55 crore in Q2 September 2008 over Q2 September 2008.
The company manufactures and distributes drugs and pharmaceuticals. The products of the group include tablets, capsules, basic drugs, orals, liquids and injectables. The group operates in Russia, Kazakhstan, Ukraine, Belarus, Uzbekistan and India.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment